18 June 2021
Chulalongkorn University Drug Discovery and Development Research Center (Chula4DR) presented the preclinical profiles of our anti-HBV lead compounds at The 17th International Symposium on Viral Hepatitis and Liver Disease, Global Hepatitis Summit 2020/2021, Taipei, Taiwan (Virtual meeting).
The presentation details and schedules are as follows:
P296
Title: Discovery and Characterization of Novel Potent Core Protein Assembly Modulators for Treatments of Chronic Hepatitis B Virus Infection.
Presenter: Udomsak Udomnilobol, Tanachote Ruengsatra, Eakkaphon Rattanangkool, Pongkorn Chaiyakunvat, Sirikarn Deesiri, Wilasinee Dunkoksung, Natthaya Chuaypen, Rattanaporn Kiatbumrung, Pornjira Somnark, Songkiat Songthammanuphap, Pisit Tangkijvanich, Khanitha Pudhom, Mark E. Duggan, Thomayant Prueksaritanont
Session: E-Poster – Basic Science: Others
Poster available to the meeting participants on June 18, 2021 at 8:00 AM (GMT+8)